MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth
{{output}}
Cholangiocarcinoma (CCA) comprises a heterogeneous group of biliary malignant tumors with poor prognosis and limited therapeutic options. Recent studies have highlighted the role of the immune system in the development and progression of intrahepatic CCA (iCCA... ...
